Britannia Life Sciences Inc.

DB:L020 Stock Report

Market Cap: €5.5m

Britannia Life Sciences Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of L020?
Owner TypeNumber of SharesOwnership Percentage
Institutions1,503,1220.926%
Individual Insiders59,673,78136.8%
General Public101,077,43662.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 4 shareholders own 37.7% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
22.8%
Peter Shippen
37,053,231€1.3m-1.85%no data
11.5%
Mark Bowes-Cavanagh
18,600,000€633.8k0%no data
2.48%
Scott Secord
4,020,550€137.0k0%no data
0.93%
Purpose Investments Inc.
1,503,122€51.2k0%no data